liquidity and to reduce the financial burden. The selling value is 40.48 % when compares to total assets from company consolidated statements. (Market Value 70,370,000.00 x 100 divided by total assets as at
, calculated from the consolidated financial statements of the Company and its subsidiaries company as of March 31, 2019 , and the said value exceeds 1 million THB but not more than 20 million THB , that is, it
2,073.19 billion) is calculated to be approximately 12.02% of the total assets of the company, based on the consolidated finance statements ending June 30, 2019. When combing with other acquisition
management in Thailand. The performance of the Company and the Company’s subsidiaries for the second quarter of 2019, the consolidated financial statement showed a net profit of 148.5 million baht, which was
revenue of the consolidated financial statements for Q2/2019 amounted 73.8 million baht compared to Q2/2018 with total revenue of 80.0 million baht, decreased 6.2 million baht or 7.7 percent. Performance
Company in the consolidated financial statement ended June 30, 2019. The company has to ask for the approval from the Board of Directors and disclose the transaction to SET immediately. Details of the
Performance Summary – by business Revenues by business THB’000 Consolidated Q2/2019 Q2/2019 ∆% Distributor of medical devices and equipment 451,157 415,547 9% Margin 163,818 160,282 2% Beauty services 33,424
results of the Company and its subsidiaries for of the second quarter of the year 2019, ended 30 June 2019 as follows: Statement of comprehensive income Statement of comprehensive income Consolidated
Company Limited (“the Company”) No. 4/2019 held on 21st August 2019, resolved as follows: 1. That the audited financial statements including the consolidated financial statements of the Company and its
The Company’s net profit from consolidated financial statement was 116.1 million Baht, increase 58.4% from the same period last year. And increase 17 million Baht or 17% from Q4/2017. The Company was